Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 3

4(40.0%)

Phase 2

1(10.0%)

10Total

N/A(5)

Phase 3(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04595942Phase 3Unknown

Midodrine and Fludrocortisone for Vasovagal Syncope

Role: collaborator

NCT02317068Phase 3Completed

Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation

Role: lead

NCT01992783Not ApplicableCompleted

Resistant Starch, Antioxidant Status and Insulin Resistance

Role: lead

NCT02070679Phase 3Completed

Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography

Role: lead

NCT02448940Not ApplicableCompleted

The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements

Role: lead

NCT02436369Not ApplicableCompleted

The Effect of Yogurt Enriched With Flaxseed on Cardiovascular Risk Factors in Type 2 Diabetic Patients

Role: lead

NCT02084069Phase 3Completed

Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

Role: lead

NCT01530243Phase 2Completed

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Role: lead

NCT02298621Not ApplicableCompleted

Pomegranate Juice and Metabolic Syndrome

Role: lead

NCT02178839Not ApplicableUnknown

The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease

Role: lead

All 10 trials loaded